Aurinia Pharmaceuticals, Inc. (AUPH)
16.58
-0.07
(-0.42%)
USD |
NASDAQ |
Aug 24, 16:00
16.58
0.00 (0.00%)
After-Hours: 20:00
Aurinia Pharmaceuticals Debt to Equity Ratio : 0.1043 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.1043 |
| March 31, 2026 | 0.1209 |
| December 31, 2025 | 0.1287 |
| September 30, 2025 | 0.2138 |
| June 30, 2025 | 0.244 |
| March 31, 2025 | 0.2225 |
| December 31, 2024 | 0.2103 |
| September 30, 2024 | 0.2264 |
| June 30, 2024 | 0.2358 |
| March 31, 2024 | 0.2463 |
| December 31, 2023 | 0.2583 |
| September 30, 2023 | 0.2379 |
| June 30, 2023 | 0.258 |
| March 31, 2023 | 0.0203 |
| December 31, 2022 | 0.0199 |
| September 30, 2022 | 0.0193 |
| June 30, 2022 | 0.0198 |
| March 31, 2022 | 0.0191 |
| December 31, 2021 | 0.0182 |
| September 30, 2021 | 0.0299 |
| June 30, 2021 | 0.0269 |
| March 31, 2021 | 0.024 |
| December 31, 2020 | 0.0206 |
| September 30, 2020 | 0.0208 |
| June 30, 2020 | 0.0259 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0222 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.0031 |
| June 30, 2019 | 0.0033 |
| March 31, 2019 | 0.003 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| enGene Therapeutics, Inc. | 0.1307 |
| Medicus Pharma Ltd. | -12.27 |
| Sirona Biochem Corp. | -- |
| Xenon Pharmaceuticals, Inc. | 0.0052 |
| Psyence Biomedical Ltd. | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 792.26M |
| Total Liabilities (Quarterly) | 177.40M |
| Shareholders Equity (Quarterly) | 614.86M |
| Current Ratio | 5.419 |
| Net Debt Paydown Yield | 0.12% |